Blar i Institutt for klinisk og molekylær medisin på forfatter "Palmer, Michael"
-
Is progression-free survival associated with a better health-related quality of life in patients with lung cancer? Evidence from two randomised trials with afatinib
Griebsch, Ingolf; Palmer, Michael; Fayers, Peter; Ellis, Stuart (Journal article; Peer reviewed, 2014)Objective: Progression-free survival (PFS) is frequently used as an efficacy end point in oncology clinical trials. However, there is limited evidence to support a positive association between improvement in PFS and ...